Love the episode? Send us a text!

What if your cancer treatment was designed just for you?

In this episode of Breast Cancer Conversations, host Dr. Laura Carfang sits down with Jim Foote, CEO and co-founder of First Ascent Biomedical, to explore how AI-powered functional precision medicine is transforming cancer care.

Instead of relying on one-size-fits-all treatment plans, this breakthrough approach tests your actual tumor cells against hundreds of FDA-approved drugs—revealing which therapies truly work for you and which don’t.

🧬 You’ll learn:

• How functional precision medicine differs from genetic testing
• Why AI and lab automation are revolutionizing oncology
• Real-life patient stories of hope and survival
• How this technology cuts costs and reduces toxicity
• Why personalization could become the new standard of care

🎧 Tune in to hear how technology, compassion, and science are coming together to rewrite the future of cancer treatment.

👉 Watch. Learn. Share. Because the future of oncology is personal.

🔗 Resources & Links:

• SurvivingBreastCancer.org
  
  
• First Ascent Biomedical
  
  
• Follow us on Instagram: @SurvivingBreastCancerOrg
  
  
• Listen on Apple Podcasts, Spotify, or wherever you get your podcasts

💬 Join the conversation:
What are your thoughts on personalized medicine? Leave a comment below and tell us how AI could change your cancer journey.

Support the show

Latest News:

• Become a Breast Cancer Conversations+ Member! Sign Up Now.
• Join our Mailing List - New content drops every Monday!